Latest Industry Insights
Industry Insight
Changing Food Sustainability One Tree at a Time
Technology Networks recently spoke with Tom Schafer, Vice President at Koch Modular Process Systems, to learn more about the pongamia tree, how its bitter taste can be processed out and the potential uses for pongamia oil.
Industry Insight
Accelerating and Refining With Mass Spectrometry
At ASMS 2023, Technology Networks spoke with Dr. Chris Lock, vice president of global research and development at SCIEX, to discuss the newly launched Intabio ZT system.
Industry Insight
Increasing Throughput While Protecting Proteome Coverage
At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Industry Insight
Advancing Biomedicine With Single-Molecule Proteomics
Unlocking more information from our proteome could deepen our understanding of disease, improve detection and influence drug selection. To find out more about single-molecule proteomics, we spoke to Parag Mallick, co-founder of Nautilus Biotech.
Industry Insight
Investigating the Long-Term Safety of ADHD Medication for Children and Adolescents
Technology Networks spoke with Dr. Sarah Inglis, trial manager of a recent study investigating the safety of a common ADHD medication, methylphenidate, in children and adolescents.
Industry Insight
Advances in Mass Spectrometry Drive Immunopeptidomics
At the 71st Annual Society for Mass Spectrometry (ASMS) meeting, Technology Networks had the pleasure of speaking with Rohan Thakur, president of Life Sciences Mass Spectrometry at Bruker Daltonics. We discussed the new product launches from Bruker and focused specifically on the applications of the company’s newest mass spectrometer, the timsTOF Ultra, for immunopeptidomics.
Industry Insight
Developing Synthetic Affinity Reagents for Improved Diagnostics
To learn more about MIPS and why they are particularly suited for use in in vitro diagnostic assays, we spoke to Dr. Francesco Canfarotta, head of chemistry at MIP Discovery.
Industry Insight
A Decade of DIA and Key Milestones: The 10-Year Anniversary of SWATH DIA
The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.
Industry Insight
Applying AI Across All Stages of Drug Development
To learn more about the application of AI across all stages of development, from drug design to clinical trials, Technology Networks spoke with Dr. Yuan Wang, head of research analytics at UCB.
Industry Insight
The Rise of Weight Management Drug Wegovy
Technology Networks spoke with Novo Nordisk’s Clinical, Medical and Regulatory Affairs team to learn more about Wegovy, its popular weight management drug.
Advertisement
